MERCADO DE DISPOSITIVOS DE ADMINISTRAÇÃO DE INSULINA - CRESCIMENTO, TENDÊNCIAS, IMPACTO DA COVID-19 e previsões (2023 - 2028)

O mercado Dispositivos de entrega de insulina é segmentado por tipo (bombas de insulina, seringas de insulina, cartuchos em canetas reutilizáveis, canetas descartáveis, injetores de jato) e geografia.

Home right-chevron-icon Industry Reports right-chevron-icon Healthcare right-chevron-icon Diabetes Drugs & Devices right-chevron-icon Insulin Delivery Devices Market right-chevron-icon Mercado de dispositivos de administração de insulina

Visão geral do mercado de dispositivos de entrega de insulina

insulin delivery devices market trends
Study Period: 2016-2027
Fastest Growing Market: North America
Largest Market: Asia Pacific
CAGR: 3.5 %

Major Players

insulin delivery devices market major players

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and it's growth?

Visão geral do mercado

Espera-se que o mercado Dispositivos de entrega de insulina registre um CAGR de 3,5% durante o período de previsão (2021 - 2026) com 33,9 bilhões de receita em 2020. alta nos últimos anos. Apesar da condição afetar milhões de pessoas em todo o mundo, cientistas e pesquisadores não conseguiram encontrar uma cura para a doença. Controlá-la pela administração adequada e oportuna de insulina continua sendo uma medida indispensável para que pacientes com diabetes tipo 1 levem uma vida normal. Assim, na ausência de uma cura completa e eficaz para o diabetes, a ênfase está principalmente em tornar a terapia com insulina melhor e mais bem-sucedida. Como um resultado,

Escopo do Relatório

O mercado de dispositivos de entrega de insulina segmentado em bombas de insulina, seringas de insulina, cartuchos em canetas reutilizáveis, canetas descartáveis ​​e injetores de jato e bomba de insulina segmentado ainda em bomba de insulina, reservatório de bomba de insulina e conjunto de infusão.

By Management Devices
Insulin Pumps
Insulin Pump Devices (Value and Volume, 2016 - 2026)
Insulin Pump Reservoirs (Value and Volume, 2016 - 2026)
Infusion Sets (Value and Volume, 2016 - 2026)
Insulin Syringes (Value and Volume, 2016 - 2026)
Cartridges in reusable pens (Value and Volume, 2016 - 2026)
Disposable Pens (Value and Volume, 2016 - 2026)
Jet Injectors (Value and Volume, 2016 - 2026)
Geography
North America
United States (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Canada (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of North America (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Europe
France (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Germany (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Italy (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Spain (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
United Kingdom (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Russia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Europe (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Latin America
Mexico (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Brazil (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Latin America (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Asia-Pacific
Japan (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Korea (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
China (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
India (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Australia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Vietnam (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Malaysia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Indonesia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Philippines (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Thailand (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Asia-Pacific (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Middle-East and Africa
Saudi Arabia (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Iran (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Egypt (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Oman (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
South Africa (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)
Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)
By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

Report scope can be customized per your requirements. Click here.

Principais tendências do mercado

Espera-se que a bomba de insulina cresça com o maior CAGR

A bomba de insulina detinha 9,2% de participação no mercado de dispositivos de administração de insulina em 2020 e deve crescer com o CAGR de 7% no mercado devido ao crescente avanço tecnológico e sua preferência sobre outros métodos tradicionais devido à administração contínua de insulina. O mercado também se beneficia enormemente do aumento constante do número de fornecedores, atividades de P&D, avanços tecnológicos em produtos e a fácil disponibilidade de produtos avançados em todo o mundo. Além disso, cenários de reembolso favoráveis ​​em países desenvolvidos e um aumento constante de programas de conscientização em economias em desenvolvimento também estão trabalhando a favor do mercado.

insulin delivery devices market share

Os Estados Unidos detinham a maior participação de mercado em 2020

Em 2020, os Estados Unidos registraram a maior participação de mercado, com mais de 20% no mercado de dispositivos de administração de insulina, seguidos pelo Japão e pela Índia. A crescente população diabética e a acessibilidade de dispositivos tecnologicamente avançados são os fatores que contribuem para o alto crescimento do mercado nos Estados Unidos. De acordo com estatísticas de inteligência de Mordor em 2020, cerca de 33 milhões de pessoas nos Estados Unidos tinham diabetes; entre eles, aproximadamente 25,8 milhões de pacientes diagnosticados, enquanto cerca de 7,1 milhões de pacientes permaneceram sem diagnóstico. Assim, espera-se que a grande base de pacientes com diabetes e sua crescente prevalência impulsionem o crescimento nesta região.

insulin delivery devices market growth

Cenário competitivo

O mercado Canetas de Insulina e Bombas de Insulina está consolidado com poucos players que representaram uma participação de mercado significativa em 2020. Por outro lado, o mercado de Seringas de Insulina é altamente fragmentado com vários players locais. Fusões e aquisições que aconteceram entre os players no passado recente ajudaram as empresas a fortalecer sua presença no mercado. Por exemplo, em julho de 2020, a Medtronic PLC e a Tandem Diabetes Care Inc. anunciaram que firmaram um contrato de licença cruzada de patente não exclusiva para certas tecnologias no campo do diabetes. 

Principais jogadores

  1. Novo Nordisk

  2. Medtronic

  3. Sanofi

  4. Ypsomed

  5. Eli Lilly e Companhia

*Disclaimer: Major Players sorted in no particular order

Novo Nordisk Medtronic Sanofi Ypsomed Eli Lilly and Company

RECENT DEVELOPMENTS

In 2020, Gan & Lee’s insulin glargine injection and insulin glargine injection (prefilled pen) obtained the registration certificates from the Brazilian National Health Surveillance Agency (ANVISA). Following this, in early 2021, the first shipments of these products were successfully delivered to Brazil.

In Aug 2020, The U.S. Food and Drug Administration approved the MiniMed 770G System, a hybrid closed-loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the users or their caregivers for use by individuals aged 2 to 6 with type 1 diabetes.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Management Devices

      1. 5.1.1 Insulin Pumps

        1. 5.1.1.1 Insulin Pump Devices (Value and Volume, 2016 - 2026)

        2. 5.1.1.2 Insulin Pump Reservoirs (Value and Volume, 2016 - 2026)

        3. 5.1.1.3 Infusion Sets (Value and Volume, 2016 - 2026)

      2. 5.1.2 Insulin Syringes (Value and Volume, 2016 - 2026)

      3. 5.1.3 Cartridges in reusable pens (Value and Volume, 2016 - 2026)

      4. 5.1.4 Disposable Pens (Value and Volume, 2016 - 2026)

      5. 5.1.5 Jet Injectors (Value and Volume, 2016 - 2026)

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value and Volume, 2016 - 2026)

          1. 5.2.1.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.1.2 Canada (Value and Volume, 2016 - 2026)

          1. 5.2.1.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.1.3 Rest of North America (Value and Volume, 2016 - 2026)

          1. 5.2.1.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      2. 5.2.2 Europe

        1. 5.2.2.1 France (Value and Volume, 2016 - 2026)

          1. 5.2.2.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.2.2 Germany (Value and Volume, 2016 - 2026)

          1. 5.2.2.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.2.3 Italy (Value and Volume, 2016 - 2026)

          1. 5.2.2.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.2.4 Spain (Value and Volume, 2016 - 2026)

          1. 5.2.2.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.2.5 United Kingdom (Value and Volume, 2016 - 2026)

          1. 5.2.2.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.2.6 Russia (Value and Volume, 2016 - 2026)

          1. 5.2.2.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 5.2.2.7 Rest of Europe (Value and Volume, 2016 - 2026)

          1. 5.2.2.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      3. 5.2.3 Latin America

        1. 5.2.3.1 Mexico (Value and Volume, 2016 - 2026)

          1. 5.2.3.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.3.2 Brazil (Value and Volume, 2016 - 2026)

          1. 5.2.3.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.3.3 Rest of Latin America (Value and Volume, 2016 - 2026)

          1. 5.2.3.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      4. 5.2.4 Asia-Pacific

        1. 5.2.4.1 Japan (Value and Volume, 2016 - 2026)

          1. 5.2.4.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.4.2 South Korea (Value and Volume, 2016 - 2026)

          1. 5.2.4.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.4.3 China (Value and Volume, 2016 - 2026)

          1. 5.2.4.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.4.4 India (Value and Volume, 2016 - 2026)

          1. 5.2.4.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.4.5 Australia (Value and Volume, 2016 - 2026)

          1. 5.2.4.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.4.6 Vietnam (Value and Volume, 2016 - 2026)

          1. 5.2.4.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        7. 5.2.4.7 Malaysia (Value and Volume, 2016 - 2026)

          1. 5.2.4.7.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        8. 5.2.4.8 Indonesia (Value and Volume, 2016 - 2026)

          1. 5.2.4.8.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        9. 5.2.4.9 Philippines (Value and Volume, 2016 - 2026)

          1. 5.2.4.9.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        10. 5.2.4.10 Thailand (Value and Volume, 2016 - 2026)

          1. 5.2.4.10.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        11. 5.2.4.11 Rest of Asia-Pacific (Value and Volume, 2016 - 2026)

          1. 5.2.4.11.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

      5. 5.2.5 Middle-East and Africa

        1. 5.2.5.1 Saudi Arabia (Value and Volume, 2016 - 2026)

          1. 5.2.5.1.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        2. 5.2.5.2 Iran (Value and Volume, 2016 - 2026)

          1. 5.2.5.2.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        3. 5.2.5.3 Egypt (Value and Volume, 2016 - 2026)

          1. 5.2.5.3.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        4. 5.2.5.4 Oman (Value and Volume, 2016 - 2026)

          1. 5.2.5.4.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        5. 5.2.5.5 South Africa (Value and Volume, 2016 - 2026)

          1. 5.2.5.5.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

        6. 5.2.5.6 Rest of Middle-East and Africa (Value and Volume, 2016 - 2026)

          1. 5.2.5.6.1 By Devices (Insulin Pumps, Insulin Syringes, Cartridges in Reusable Pens, Disposable Pens, and Jet Injectors)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes population (2016- 2026)

    2. 6.2 Type-2 Diabetes population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company profiles

      1. 7.1.1 Novo Nordisk

      2. 7.1.2 Sanofi

      3. 7.1.3 Eli Lilly and Company

      4. 7.1.4 Medtronic

      5. 7.1.5 Insulet

      6. 7.1.6 Ypsomed

      7. 7.1.7 Becton, Dickinson and Company

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

O mercado de Dispositivos de administração de insulina é estudado de 2018 a 2028.

O mercado de dispositivos de administração de insulina está crescendo a um CAGR > 3% nos próximos 5 anos.

O mercado de dispositivos de administração de insulina está avaliado em 36 bilhões de dólares em 2018.

O mercado de dispositivos de administração de insulina está avaliado em 43 bilhões de dólares em 2028.

A América do Norte está crescendo no CAGR mais alto de 2018 a 2028.

A Ásia-Pacífico detém a maior participação em 2021.

Novo Nordisk, Medtronic, Sanofi, Ypsomed, Eli Lilly and Company são as principais empresas que operam no mercado de dispositivos de administração de insulina.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!